13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)

Page 4 of 10

Page 4 of 10 – SEC Filing


CUSIP No. 09069N108 (Common Stock)

  1.

Names of
Reporting Persons.

Coliseum Capital Partners, L.P.

  2.

Check the Appropriate Box if a Member
of a Group (See Instructions)

(a)  ☐        (b)  ☒

  3.

SEC Use Only

  4.

Source of Funds (See Instructions)

WC

  5.

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)

  6.

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7.

Sole Voting Power

0

  8.

Shared Voting Power

15,204,502 (1)

  9.

Sole Dispositive Power

0

10.

Shared Dispositive Power

15,204,502 (1)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

15,204,502 (1)

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (See Instructions)

13.

Percent of Class Represented by
Amount in Row (11)

10.9% (1)

14.

Type of Reporting Person (See
Instructions)

PN

(1) Includes (a) 2,945,866 Common Shares, (b) 173,019 Common Shares that could be obtained upon conversion of 6,813 Series A Preferred Shares, (c) 9,819,242 Common Shares that could be obtained upon conversion of 386,655
Series C Preferred Shares, (d) 1,133,188 Common Shares that could be obtained upon conversion of 1,133,188 Class A Warrants, and (e) 1,133,188 Common Shares that could be obtained upon conversion of 1,133,188 Class B Warrants.

Page 4 of 10

Follow Option Care Health Inc. (NASDAQ:OPCH)

Page 4 of 10